Michael's practice focuses on the representation of start-up and emerging growth companies in the life science industry, and middle market and family owned companies in a broad range of industries. Michael also serves as investors’ counsel for venture capital firms which invest in life science companies on a regular basis.
Michael’s life science clients include medical device, pharmaceutical, drug discovery and biopharmaceutical companies. He works closely with the management teams of these companies in addressing all of their legal issues and represents them on a regular basis with respect to private and public financing transactions, strategic alliances and M&A transactions.
For more than 40 years, Michael has been representing and advising middle market and family owned companies. He provides these clients with general corporate representation and advises them with respect to their day-to-day legal matters, including management and corporate governance issues. He also represents these clients in connection with financing, merger, acquisition and divestiture transactions. Michael also provides guidance to family owned businesses with respect to succession planning.
